Literature DB >> 18558503

Sub-chronic rolipram treatment leads to a persistent improvement in long-term object memory in rats.

K Rutten1, J Prickaerts, G Schaenzle, H Rosenbrock, A Blokland.   

Abstract

In the present study the effects of sub-chronic rolipram treatment in an object recognition task in 3-month-old male rats were investigated. Rats remember which object they have explored in a previous trial (T1) when they are tested 1 h later (T2). However, when tested 24 h later, they do not remember which object was presented to them in the first trial. Drug treatments may improve discrimination performance after 24 h, i.e., improve memory for the familiar object. Rats were sub-chronically treated with 0.5 mg/kg rolipram (p.o.) for five consecutive days and tested with a 24 h delay between T1 and T2. Memory performance in the object recognition task was assessed before, during and after sub-chronic treatment. In addition, we investigated whether the timing of the final dose, i.e., 24, 1, or 6 h before training, had an effect on memory performance. During sub-chronic treatment, i.e., after 2-3 days of rolipram treatment, moderate effects on memory performance were observed. Regardless of when the final administration was given, sub-chronic rolipram treatment improved long-term memory performance. Since plasma and brain rolipram levels were undetectable at 24 h before the test, and acute treatment with rolipram 24 h before training had no effects, the observed memory enhancement cannot be attributed to acute rolipram effects. The long-term memory enhancing effects of rolipram might be explained by long-lasting neuronal changes by the chronic treatment due to recurring activation of the cAMP/PKA/CREB pathway leading to CREB phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18558503     DOI: 10.1016/j.nlm.2008.04.016

Source DB:  PubMed          Journal:  Neurobiol Learn Mem        ISSN: 1074-7427            Impact factor:   2.877


  9 in total

1.  RNA interference-mediated phosphodiesterase 4D splice variants knock-down in the prefrontal cortex produces antidepressant-like and cognition-enhancing effects.

Authors:  Zhen-Zhen Wang; Yi Zhang; Yan-Qin Liu; Nan Zhao; You-Zhi Zhang; Li Yuan; Lei An; Jing Li; Xiao-Yun Wang; Juan-Juan Qin; Steven P Wilson; James M O'Donnell; Han-Ting Zhang; Yun-Feng Li
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

Review 2.  Cyclic GMP and nitric oxide synthase in aging and Alzheimer's disease.

Authors:  Katarzyna Urszula Domek-Łopacińska; Joanna B Strosznajder
Journal:  Mol Neurobiol       Date:  2010-03-09       Impact factor: 5.590

Review 3.  Modeling cognitive dysfunction in neurofibromatosis-1.

Authors:  Kelly A Diggs-Andrews; David H Gutmann
Journal:  Trends Neurosci       Date:  2013-01-08       Impact factor: 13.837

Review 4.  Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia.

Authors:  Jared W Young; Susan B Powell; Victoria Risbrough; Hugh M Marston; Mark A Geyer
Journal:  Pharmacol Ther       Date:  2009-03-06       Impact factor: 12.310

5.  Rolipram treatment during consolidation ameliorates long-term object location memory in aged male mice.

Authors:  Mathieu E Wimmer; Jennifer M Blackwell; Ted Abel
Journal:  Neurobiol Learn Mem       Date:  2020-01-19       Impact factor: 2.877

Review 6.  Understanding PDE4's function in Alzheimer's disease; a target for novel therapeutic approaches.

Authors:  Amy J Tibbo; Gonzalo S Tejeda; George S Baillie
Journal:  Biochem Soc Trans       Date:  2019-10-31       Impact factor: 5.407

Review 7.  Selective phosphodiesterase inhibitors: a promising target for cognition enhancement.

Authors:  Olga A H Reneerkens; Kris Rutten; Harry W M Steinbusch; Arjan Blokland; Jos Prickaerts
Journal:  Psychopharmacology (Berl)       Date:  2008-08-16       Impact factor: 4.530

8.  PDE4 inhibition enhances hippocampal synaptic plasticity in vivo and rescues MK801-induced impairment of long-term potentiation and object recognition memory in an animal model of psychosis.

Authors:  V Wiescholleck; D Manahan-Vaughan
Journal:  Transl Psychiatry       Date:  2012-03-13       Impact factor: 6.222

9.  Dominant-Negative Attenuation of cAMP-Selective Phosphodiesterase PDE4D Action Affects Learning and Behavior.

Authors:  Graeme B Bolger; Lisa High Mitchell Smoot; Thomas van Groen
Journal:  Int J Mol Sci       Date:  2020-08-09       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.